Pfizer drops as Covid-19 capsule fails in preventive treatment experiment
(MENAFN) Pfizer company collapsed after Paxlovid, its capsule for treating Covid-19, was unsuccessful in healing as a preventive treatment in an experimental.
in line with analytics group Airfinity Ltd, Paxlovid is confident to turn into one of the fastest-selling medications of all time, with USD24 billion in estimated sales this year.
Pfizer has also gained billions in worldwide trades from its COVID-19 injection.
On Friday, the firm stated that the medication was unsuccessful to reach its major aim of decreasing the danger that adults subjected to the coronavirus through interaction with a family member would become diseased.
The stocks dropped 2.2 percent at 9:36 AM in New York, They had dropped 17 percent in 2022 through Friday’s end.
MENAFN08052022000045014228ID1104177143
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.